Physician profile
Daniel A Duffy
NPI 1275568016
$2,602.40
in general payments reported to CMS, 2019-2025
19 companies · $527 in 2025
The $527 reported for 2025 was more than what 80% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $261 · 2020: $189 · 2021: $458 · 2022: $243 · 2023: $276 · 2024: $648 · 2025: $527.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,451.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,451.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $843.58 | 2022-2025 | Botox, Ubrelvy |
| Ipsen Biopharmaceuticals, INC | $816.76 | 2019-2025 | Dysport |
| Allergan, INC. | $388.64 | 2019-2022 | |
| Neurocrine Biosciences, INC. | $95.73 | 2019-2022 | |
| Radius Health, INC. | $68.38 | 2019-2021 | |
| Lundbeck LLC | $56.54 | 2025 | Vyepti |
| Bioventus LLC | $49.58 | 2024-2025 | Durolane, Xcell |
| Lilly USA, LLC | $40.26 | 2021 | |
| Pfizer INC. | $36.86 | 2020-2021 | |
| Amgen INC. | $34.54 | 2019-2022 | |
| Merz Pharmaceuticals, LLC | $28.53 | 2022-2025 | Xeomin |
| Saol Therapeutics INC. | $25.41 | 2019 | |
| Avanir Pharmaceuticals, INC. | $25.39 | 2022 | |
| Fidia Pharma USA INC. | $18.02 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $17.34 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $15.11 | 2019 | |
| Collegium Pharmaceutical, INC. | $15.06 | 2025 | Xtampza |
| Sunovion Pharmaceuticals INC. | $14.27 | 2020 | |
| Merck Sharp & Dohme LLC | $12.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Duffy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.